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Transient thyroiditis after surgery
for tertiary hyperparathyroidism:
a case report
Yasser Ali Hakami*
Obesity, Endocrine and Metabolism Center, King Fahad Medical City, Riyadh, Saudi Arabia
Parathyroid (PTH) exploration surgery carries the risk of developing post-operative
thyroiditis due to vigorous manual manipulation of the thyroid gland during surgery. Post-
operative thyroiditis has a wide spectrum of clinical manifestations. However, it remains
underreported. Here, we describe a case of post-operative transient thyroiditis in a 33-
year-old male who developed 3days after parathyroidectomy for PTH hyperplasia. We
review the limited literature regarding this interesting entity.
Keywords: thyroiditis, thyroid function tests, hyperparathyroidism, post-operative period, parathyroidectomy,
adrenergic beta-antagonists
Introduction
Post-operative thyroiditis is one cause of iatrogenic thyrotoxicosis. It usually occurs after vigorous
manual manipulation of the thyroid gland during neck or parathyroid (PTH) exploratory surgery.
It has a wide spectrum of clinical manifestations, varying from asymptomatic hyperthyroxinemia to
a severe overt thyrotoxic state (1).
However, this disorder remains underestimated and only a few cases have been reported. In
current clinical practice, this condition is likely more common and important than previously
thought.
Case Report
A 33-year-old male came to the clinic complaining of generalized bone pain associated with
progressive weakness over the last year. The patient had been diagnosed with end-stage renal disease
secondary to glomerulonephritis 11 years before his presentation and had been on hemodialysis
three times per week for the last 10 years. The patient had no past history of thyroid disorders. There
was no goiter on physical examination.
The patient’s serum corrected-calcium level was 2.79mmol/L (normal range, 2.19–2.54mmol/L),
his serum phosphate level was 1.29mmol/L (normal range, 0.7–1.5mmol/L), his vitamin D25-OH
level was normal, his serum creatinine level was 756μmol/L (normal range, 53–106.1μmol/L),
his serum urea was 17.2mmol/L (normal range, 2.9–8.2mmol/L), and his serum PTH level was
489.5 pmol/L (normal range, 1.6–6.8 pmol/L).
At our clinic, the patient was diagnosed with tertiary hyperparathyroidism and renal osteodystro-
phy as complications from his chronic kidney disease. His pre-operative serum thyroid-stimulating
hormone (TSH) level was within normal parameters (1.1mIU/L; normal range, 0.35–5.0mIU/L).
A dual-phase PTH scan revealed two foci located below the lower poles of both thyroid lobes with
intact thyroid uptake compatible with PTH adenomas (Figure 1). Diagnostic computed tomography
(CT) or magnetic resonance imaging (MRI) scans were necessary for the final reading, which
involved fusion of the available axial cuts of the PTH scan with structural imaging data. Neck MRI
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FIGURE 1 | The patient’s FT4 levels peaked on post-operative day 3.
Reference values are the following: free thyroxine (FT4): 9.1–23.8 pmol/L.
revealed four PTH masses posterior and inferior to the normal
thyroid gland, with two masses on each side, suggesting PTH
adenomas. Fine-needle aspiration (FNA) of the right PTHmasses
was performed, and pathological examination revealed PTH cells
consistent with hyperplastic proliferation. Therefore, the patient
was diagnosed with PTH hyperplasia.
The patient underwent parathyroidectomy to remove his PTH
glands. He was brought to the operating room under general
anesthesia. A transverse incision 6-cm long and 3-cm superior
to the sternal angle was made. The strap muscle was separated,
and the dissection was continued until the surgeon reached the
thyroid gland. Retraction of the thyroid gland on the right side
was successful, and the recurrent laryngeal nerve was identified.
The superior right PTH gland was anterior to the nerve and was
dissected successfully. The inferior right PTH gland was deep and
near the sternum. It was difficult to separate the inferior right
PTH gland from the thyroid gland surgically because they were
firmly attached, so the attached part of the thyroid glandwas taken
as a resection margin along with the inferior right PTH gland.
Subcapsular dissection of the thyroid gland was done on the left
side also, and the left recurrent laryngeal nerve was identified. The
superior left PTH gland, posterior to the nerve, was identified and
separated successfully. The left inferior PTH gland was located,
dissected from around the gland, and extracted. All of the PTH
glands were resected. The duration of the surgery was 78min.
The intra-operative serumPTH level was 414.2 pmol/L and had
declined to 22.4 pmol/L 1 h after surgery. One day after surgery, it
was 4.2 pmol/L. The resected part of the thyroid gland was normal
on pathological examination. The pathological examination of
the resected PTH glands revealed nodular hyperplasia involving
all glands confirming the PTH hyperplasia diagnosis. There were
no complications during surgery. However, the patient developed
hypocalcemia that was normalized with calcium replacement
therapy.
Three days after the surgery, the patient presented with
new symptoms of palpitation, anxiety, and hand tremors. A
complete examination revealed mild, diffuse, non-tender goiter,
FIGURE 2 | The patient’s TSH levels following surgery. Reference values
are the following: thyroid-stimulating hormone (TSH): 0.35–5.0mIU/L.
and fine tremor, with stable vital signs. Serum thyroid function
tests revealed that his TSH level was 0.171mIU/L and that
his free thyroxine (FT4) level was 97.6 pmol/L (normal range,
9.1–23.8 pmol/L), consistent with primary hyperthyroidism
(Figures 2 and 3). Technetium-99m (Tc-99m) pertechnetate
scintigraphy revealed generalized reduced tracer uptake in the
thyroid gland, a finding that is compatible with thyroiditis
(Figure 4). Autoimmune markers were normal, including
thyroglobulin (Tg) antibodies (2.08 IU/mL; normal range,
0–80 IU/mL), thyroid peroxidase (TPO) antibodies (0.3 IU/mL;
normal range, 0–20 IU/mL), and TSH receptor antibodies
(negative). However, inflammatory markers were elevated
including C-reactive protein (CRP) (8.8mg/L; normal range,
1.0–3.0mg/L) and erythrocyte sedimentation rate (ESR)
(78mm/H; normal range, 0.0–20.0mm/H). There was no clinical
evidence of sepsis. The patient did not receive iodinated contrast
agents; he did not receive lithium or amidarone nor medication
that might have affected his thyroid function tests. Other
possible causes of thyroiditis have been ruled out, specifically,
viral thyroiditis, bacterial thyroiditis, autoimmune thyroiditis,
radiation thyroiditis, or drug-induced thyroiditis. Therefore, he
was diagnosed with post-operative thyroiditis and given oral
Bisoprolol. He did not receive an antithyroid agent.
His condition improved over the following weeks. After
3weeks, he made a complete recovery and had no persistent
clinical or biochemical manifestations of thyroid disease. Biso-
prolol was withdrawn. The patient was examined in the clinic
after 6months. At this time, he was clinically and biochemically
euthyroid, with no indication of hypothyroidism.
A definitive diagnosis of post-operative transient thyroiditis
secondary due to manual manipulation of the thyroid gland
during surgery was made.
Discussion
The incidence of post-operative thyroiditis is unknown as it is
underreported. There are no data in the literature pertaining to
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FIGURE 3 | 99m TcMIBI (sestamibi) dual-phase parathyroid scintigraphy revealed two foci located below the lower poles of both thyroid lobes with
intact thyroid uptake compatible with parathyroid adenomas.
complications of parathyroidectomy on the prevalence of post-
operative transient thyroiditis. This is likely because most patients
are asymptomatic or have mild non-specific symptoms.
In 2005, Stang et al. examined pre- and post-operative thyroid
function and outcomes in 199 patients who had PTH exploratory
surgery for primary sporadic hyperparathyroidism. They found
that the incidence of TSH suppression below the lower limits of
normal levels was 29% (58/199) (1). Akira et al. reported a type
of thyrotoxicosis that occurred after needle aspiration of thyroid
cysts. The incidence of post-aspiration thyrotoxicosis was 0.9% (1
of 115) (2). In two small studies, the rate of post-operative hyper-
thyroidism after parathyroidectomy was 20% (3, 4). Reported
causes of iatrogenic thyrotoxicosis include use of medication that
can affect the thyroid gland, such as lithium and amiodarone,
recent radioiodine ablation, thyroid hormone replacement ther-
apy, iodine excess, immunotherapy, external irradiation, and
manipulation of the thyroid gland during surgery.
The exact mechanism of post-operative thyroiditis is unclear.
In the past, hyperthyroidism arising after PTH surgery has been
thought to be transient and relate to retraction of the thyroid gland
for exposure during surgery.
In 1975, Carney et al. described an association between vigor-
ous thyroid lobe palpations under pentobarbital anesthesia with
the histological finding of granulomatous thyroid folliculitis in
massaged thyroid lobes in dogs. Noting that similar multifocal
inflammatory changes usually were present in resected human
thyroid lobes. It is suggested that manipulation of the thyroid
gland was sufficient to cause transient inflammatory reactions in
both humans and dogs, which they termed as palpation thyroiditis
and multifocal granulomatous folliculitis (5).
In 1992, Walfish et al. reported on three patients who had
undergone resection of PTH adenoma, which occurred after rou-
tine transection of the superior thyroid pole and vessels and devel-
oped thyrotoxicosis post-operatively. They concluded that the
thyroid disruption caused post-operative hyperthyroidism. They
were the first to suggest evidence of a clinical syndrome of trauma-
induced thyroiditis in those patients (6). On the contrary, in Stang
et al. study, they treat the thyroid gland as gently as possible, but
there data supported a causative role of operative trauma to the
thyroid lobe, since bilateral exploration was associated with the
development of post-operative hyperthyroidism (1).
In Akira et al. study, the mechanism of post-aspiration thy-
rotoxicosis is unknown; however, they speculated that the com-
bination of thyroiditis and leakage of thyroid contents into the
cystmight have triggered thyroid hormone release into circulation
after needle aspiration of thyroid cysts (2). In Bergenfelz et al.
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FIGURE 4 | Technetium-99m (Tc-99m) pertechnetate scintigraphy of
the patient’s thyroid gland is faintly observed with generalized reduced
tracer uptake in the thyroid gland. There is increased background tracer
activity in the salivary glands. These findings are compatible with thyroiditis.
prospective study of 20 patients undergoing operation for pri-
mary hyperparathyroidism, compared with 6 patients undergo-
ing laparoscopic cholecystectomy. Four patients (20%) developed
biochemical hyperthyroidism, but serum antithyroid antibody
levels did not increase. Control patients experienced a slight
increase in mean TSH post-operatively, and the authors con-
cluded that post-parathyroidectomy hyperthyroidism was related
to metabolic derangement intrinsic to the primary hyperparathy-
roidism itself (3).
In Lindblom et al. report, they examined post-
parathyroidectomy hyperthyroidism in 26 patients undergoing
operation for primary hyperparathyroidism, but with more
detail about anesthetic and operative factors and with a different
control group of 11 patients undergoing breast cancer surgery.
Post-operative levels of T4 and T3 were higher after PTH
operation than after breast operation. The investigator concluded
that manipulation of the thyroid gland was most likely the major
contributing factor to post-operative hyperthyroidism. However,
it may not be the sole explanation, since there data suggest a more
multifactorial scenario (4).
Rudofsky et al. reported a case of transient symptomatic thyro-
toxicosis following PTH surgery for tertiary hyperparathyroidism
in a 33-year-old woman; they presumed that it was caused by a
traumatic thyroiditis as a result of manipulation of the thyroid
gland during surgery (7).
Calle and Cohen reported on a patient who developed transient
thyroiditis following total laryngopharyngoesophagectomy with
gastric pull-up for a right hypopharynx tumor with preservation
of the thyroid gland (8).
In the Stang et al. study cited above, the incidence of
post-operative hyperthyroidism was independent of age, gender,
the pre-operative and intra-operative PTH levels, and adenoma
weight. There was no relationship between the type of PTH
pathology, that is, multi-glandular disease versus solitary ade-
noma, the presence of goiter, or prior thyroiditis. None of the
following indicators of operative trauma were predictive of post-
operative thyroiditis: time that the operation took, incision length,
difficulty in making the dissection, thyroid nodulectomy, thy-
roidectomy for intrathyroidal PTH adenoma, retropharyngeal
adenoma, concurrent cervical thymectomy, the degree of perithy-
roidal inflammation, or whether or not a drain was placed (1).
Stang et al. identified three surgical variables associated with
post-parathyroidectomy hyperthyroidism. These were bilateral
exploration, the absence of concurrent thyroid lobectomy, and
performance of the operation at community hospitals. When
patients were cared for at the community hospitals, exploration
had to be done bilaterally because the intra-operative PTH could
not be monitored. The use of lithium was observed to be an
independent risk factor for post-operative hyperthyroidism. This
may be because lithiumprovides a persistent toxic insult to thyroid
tissue, rendering it more sensitive to manipulation during neck
surgery. Patients who underwent complete thyroid lobectomy
were less likely to have post-operative thyroiditis (1).
Post-operative thyroiditis has a wide clinical presentation spec-
trum, ranging from asymptomatic hyperthyroxinemia to severe
hyperthyroidism. In addition, a few cases of thyroiditis following
neck surgery that caused the onset of atrial fibrillation have been
reported (9, 10). McDermott et al. reported a case of transient thy-
roiditis secondary to surgical manipulation of the thyroid in a 76-
year-old man, which caused significant tachyarrhythmia follow-
ing total laryngectomy for a subglottic tumor with preservation of
thyroid gland (11).
In the Stang et al. study, hyperthyroidism symptoms were
reported in 19 of 125 (15%) patents with pre-operatively nor-
mal serum TSH levels. Of these, five patients (4%) were found
to be overtly thyrotoxic. The duration for complete biochem-
ical resolution ranged from 12 days to 90 days post-operation,
whether or not there was medical management (1). The finding
that there was spontaneous resolution of the condition within
6weeks in the majority of the patients supports the hypothesis
that manipulation of the gland during parathyroidectomy is a
major contributing factor in its development. Development of
thyrotoxicosis withmore prolonged hyperthyroxinemia later than
6weeks after surgery may be caused by other factors, includ-
ing lithium therapy or a predisposition to Grave’s disease (12).
It is not clear that permanent hypothyroidism is common in
these cases, as there are few data on this question. There is
also little information on how an abnormal thyroid status will
affect the development of post-operative thyroiditis compared
to patients with a normal thyroid. Nonetheless, it would appear
to be prudent to follow up patients who suffered post-operative
thyroiditis for permanent hypothyroidism. In all cases, symp-
tomatic treatment should be applied until spontaneous resolution
of symptoms.
We speculate that there is an association between vigorous
manual manipulation of the thyroid gland during PTH explo-
ration surgery and the incidence of post-operative transient thy-
roiditis.
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Further retrospective and prospective studies should be
conducted to confirm the association between vigorous manual
manipulation of the thyroid gland during PTH exploration
surgery and the incidence of post-operative thyroiditis. They
should also address identification of the risk factors and the
patients who should undergo additional testing. This would be
important to enhance our understanding of the disease process,
and establish the clinical criteria for accurate diagnosis and early
treatment.
Post-operative thyroiditis can cause significant clinical prob-
lems that can be easilymissed. Clinicians should have an increased
awareness of the clinical consequences and complications.
Establishing the risks inherent to PTH exploration surgery
should enable clinicians to develop strategies for effective risk
reduction, such as minimizing the extent of surgery.
Based on the current literature data, the authors recom-
mend pre-operative counseling as well as routine biochemi-
cal and clinical surveillance for hyperthyroidism during the
post-operative period. Although diagnosis should be early and
expectant, treatment should be symptomatic as allowed by
spontaneous resolution of symptoms. Continued efforts to
minimize the extent of PTH exploration surgery, if possi-
ble, may reduce the potential morbidity of thyrotoxicosis after
surgery.
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